98 related articles for article (PubMed ID: 12455229)
1. 4'-C-substituted-2'-deoxynucleosides: a family of antiretroviral agents which are potent against drug-resistant HIV variants.
Ohrui H; Mitsuya H
Curr Drug Targets Infect Disord; 2001 May; 1(1):1-10. PubMed ID: 12455229
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vitro activity of long-chain 5'-O-[(alkoxycarbonyl)phosphinyl]-3'-azido-3'-deoxythymidines against wild-type and AZT- and foscarnet-resistant strains of HIV-1.
Rosowsky A; Fu H; Pai N; Mellors J; Richman DD; Hostetler KY
J Med Chem; 1997 Aug; 40(16):2482-90. PubMed ID: 9258355
[TBL] [Abstract][Full Text] [Related]
3. 4'-Ethynyl nucleoside analogs: potent inhibitors of multidrug-resistant human immunodeficiency virus variants in vitro.
Kodama EI; Kohgo S; Kitano K; Machida H; Gatanaga H; Shigeta S; Matsuoka M; Ohrui H; Mitsuya H
Antimicrob Agents Chemother; 2001 May; 45(5):1539-46. PubMed ID: 11302824
[TBL] [Abstract][Full Text] [Related]
4. A 4'-C-ethynyl-2',3'-dideoxynucleoside analogue highlights the role of the 3'-OH in anti-HIV active 4'-C-ethynyl-2'-deoxy nucleosides.
Siddiqui MA; Hughes SH; Boyer PL; Mitsuya H; Van QN; George C; Sarafinanos SG; Marquez VE
J Med Chem; 2004 Oct; 47(21):5041-8. PubMed ID: 15456247
[TBL] [Abstract][Full Text] [Related]
5. Potential of 4'-C-substituted nucleosides for the treatment of HIV-1.
Hayakawa H; Kohgo S; Kitano K; Ashida N; Kodama E; Mitsuya H; Ohrui H
Antivir Chem Chemother; 2004 Jul; 15(4):169-87. PubMed ID: 15457679
[TBL] [Abstract][Full Text] [Related]
6. 2'-deoxy-4'-C-ethynyl-2-halo-adenosines active against drug-resistant human immunodeficiency virus type 1 variants.
Kawamoto A; Kodama E; Sarafianos SG; Sakagami Y; Kohgo S; Kitano K; Ashida N; Iwai Y; Hayakawa H; Nakata H; Mitsuya H; Arnold E; Matsuoka M
Int J Biochem Cell Biol; 2008; 40(11):2410-20. PubMed ID: 18487070
[TBL] [Abstract][Full Text] [Related]
7. Syntheses of 4'-C-ethynyl-beta-D-arabino- and 4'-C-ethynyl-2'-deoxy-beta-D-ribo-pentofuranosylpyrimidines and -purines and evaluation of their anti-HIV activity.
Ohrui H; Kohgo S; Kitano K; Sakata S; Kodama E; Yoshimura K; Matsuoka M; Shigeta S; Mitsuya H
J Med Chem; 2000 Nov; 43(23):4516-25. PubMed ID: 11087576
[TBL] [Abstract][Full Text] [Related]
8. Activity against human immunodeficiency virus type 1, intracellular metabolism, and effects on human DNA polymerases of 4'-ethynyl-2-fluoro-2'-deoxyadenosine.
Nakata H; Amano M; Koh Y; Kodama E; Yang G; Bailey CM; Kohgo S; Hayakawa H; Matsuoka M; Anderson KS; Cheng YC; Mitsuya H
Antimicrob Agents Chemother; 2007 Aug; 51(8):2701-8. PubMed ID: 17548498
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and anti-HIV activity of 2'-deoxy-2'-fluoro-4'-C-ethynyl nucleoside analogs.
Wang Q; Li Y; Song C; Qian K; Chen CH; Lee KH; Chang J
Bioorg Med Chem Lett; 2010 Jul; 20(14):4053-6. PubMed ID: 20542430
[TBL] [Abstract][Full Text] [Related]
10. Effects of the Delta67 complex of mutations in human immunodeficiency virus type 1 reverse transcriptase on nucleoside analog excision.
Boyer PL; Imamichi T; Sarafianos SG; Arnold E; Hughes SH
J Virol; 2004 Sep; 78(18):9987-97. PubMed ID: 15331732
[TBL] [Abstract][Full Text] [Related]
11. Drug resistance and drug combination features of the human immunodeficiency virus inhibitor, BCH-10652 [(+/-)-2'-deoxy-3'-oxa-4'-thiocytidine, dOTC].
Taylor DL; Ahmed PS; Tyms AS; Wood LJ; Kelly LA; Chambers P; Clarke J; Bedard J; Bowlin TL; Rando RF
Antivir Chem Chemother; 2000 Jul; 11(4):291-301. PubMed ID: 10950391
[TBL] [Abstract][Full Text] [Related]
12. l-2',3'-Didehydro-2',3'-dideoxy-3'-fluoronucleosides: synthesis, anti-HIV activity, chemical and enzymatic stability, and mechanism of resistance.
Chong Y; Gumina G; Mathew JS; Schinazi RF; Chu CK
J Med Chem; 2003 Jul; 46(15):3245-56. PubMed ID: 12852755
[TBL] [Abstract][Full Text] [Related]
13. 3'-Azido-3'-deoxythymidine (AZT) and AZT-resistant reverse transcriptase can increase the in vivo mutation rate of human immunodeficiency virus type 1.
Mansky LM; Bernard LC
J Virol; 2000 Oct; 74(20):9532-9. PubMed ID: 11000223
[TBL] [Abstract][Full Text] [Related]
14. Design, efficient synthesis, and anti-HIV activity of 4'-C-cyano- and 4'-C-ethynyl-2'-deoxy purine nucleosides.
Kohgo S; Yamada K; Kitano K; Iwai Y; Sakata S; Ashida N; Hayakawa H; Nameki D; Kodama E; Matsuoka M; Mitsuya H; Ohrui H
Nucleosides Nucleotides Nucleic Acids; 2004; 23(4):671-90. PubMed ID: 15200030
[TBL] [Abstract][Full Text] [Related]
15. MK-8591 (4'-Ethynyl-2-Fluoro-2'-Deoxyadenosine) Exhibits Potent Activity against HIV-2 Isolates and Drug-Resistant HIV-2 Mutants in Culture.
Wu VH; Smith RA; Masoum S; Raugi DN; Ba S; Seydi M; Grobler JA; Gottlieb GS;
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559249
[TBL] [Abstract][Full Text] [Related]
16. 2'-deoxy-4'-C-ethynyl-2-fluoroadenosine: a nucleoside reverse transcriptase inhibitor with highly potent activity against wide spectrum of HIV-1 strains, favorable toxic profiles, and stability in plasma.
Ohrui H; Kohgo S; Hayakawa H; Kodama E; Matsuoka M; Nakata T; Mitsuya H
Nucleosides Nucleotides Nucleic Acids; 2007; 26(10-12):1543-6. PubMed ID: 18066823
[TBL] [Abstract][Full Text] [Related]
17. Pyrrolobenzoxazepinone derivatives as non-nucleoside HIV-1 RT inhibitors: further structure-activity relationship studies and identification of more potent broad-spectrum HIV-1 RT inhibitors with antiviral activity.
Campiani G; Morelli E; Fabbrini M; Nacci V; Greco G; Novellino E; Ramunno A; Maga G; Spadari S; Caliendo G; Bergamini A; Faggioli E; Uccella I; Bolacchi F; Marini S; Coletta M; Nacca A; Caccia S
J Med Chem; 1999 Oct; 42(21):4462-70. PubMed ID: 10543890
[TBL] [Abstract][Full Text] [Related]
18. Delayed emergence of HIV-1 variants resistant to 4'-ethynyl-2-fluoro-2'-deoxyadenosine: comparative sequential passage study with lamivudine, tenofovir, emtricitabine and BMS-986001.
Maeda K; Desai DV; Aoki M; Nakata H; Kodama EN; Mitsuya H
Antivir Ther; 2014; 19(2):179-89. PubMed ID: 24162098
[TBL] [Abstract][Full Text] [Related]
19. Side-chain derivatives of biologically active nucleosides. 1. Side-chain analogs of 3'-azido-3'-deoxythymidine (AZT).
Hiebl J; Zbiral E; Balzarini J; De Clercq E
J Med Chem; 1992 Aug; 35(16):3016-23. PubMed ID: 1323681
[TBL] [Abstract][Full Text] [Related]
20. The Nucleoside Analog BMS-986001 Shows Greater In Vitro Activity against HIV-2 than against HIV-1.
Smith RA; Raugi DN; Wu VH; Leong SS; Parker KM; Oakes MK; Sow PS; Ba S; Seydi M; Gottlieb GS;
Antimicrob Agents Chemother; 2015 Dec; 59(12):7437-46. PubMed ID: 26392486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
